Eyebright Medical Technology (Beijing) Balance Sheet Health
Financial Health criteria checks 5/6
Eyebright Medical Technology (Beijing) has a total shareholder equity of CN¥2.5B and total debt of CN¥614.8M, which brings its debt-to-equity ratio to 24.2%. Its total assets and total liabilities are CN¥3.4B and CN¥863.1M respectively. Eyebright Medical Technology (Beijing)'s EBIT is CN¥412.0M making its interest coverage ratio 34.3. It has cash and short-term investments of CN¥469.3M.
Key information
24.2%
Debt to equity ratio
CN¥614.83m
Debt
| Interest coverage ratio | 34.3x |
| Cash | CN¥469.25m |
| Equity | CN¥2.54b |
| Total liabilities | CN¥863.14m |
| Total assets | CN¥3.41b |
Recent financial health updates
Recent updates
We Think That There Are Some Issues For Eyebright Medical Technology (Beijing) (SHSE:688050) Beyond Its Promising Earnings
Nov 06
Returns At Eyebright Medical Technology (Beijing) (SHSE:688050) Are On The Way Up
Oct 18Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Oct 01Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 23Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Financial Position Analysis
Short Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥247.5M).
Long Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥615.6M).
Debt to Equity History and Analysis
Debt Level: 688050's net debt to equity ratio (5.7%) is considered satisfactory.
Reducing Debt: 688050's debt to equity ratio has increased from 0.1% to 24.2% over the past 5 years.
Debt Coverage: 688050's debt is well covered by operating cash flow (48.6%).
Interest Coverage: 688050's interest payments on its debt are well covered by EBIT (34.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 10:32 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eyebright Medical Technology (Beijing) Co., Ltd. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Yichi Zhang | China International Capital Corporation Limited |
| Feifei Xu | China Merchants Securities Co. Ltd. |